Based in California, Lumitron Technologies Inc. was established to develop and commercialize unique x‐ray systems that enable revolutionary new capabilities for ultrahigh‐fidelity imaging, ultra‐low dose radiography, hyper‐precision radiotherapy, as well as element-specific and isotope-specific material identification, assay and imaging.
Lumitron is pioneering a new class of high-energy, laser-Compton light sources with monochromatic, 100 keV-class x-ray outputs comparable to the those from facility-scale modern synchrotrons and monochromatic gamma-ray outputs many orders of magnitude beyond even the largest synchrotrons. For healthcare, the company intends to enable precision k-edge subtraction imaging and targeted, Auger-cascade therapy at the point of use with a form factor that will fit in existing clinical treatment environments. The technology targets vastly enhanced resolution with significant reductions in dosage enabling orders of magnitude improvement in current imaging and therapeutic modalities.
Lumitron utilizes proprietary x-ray and laser technology conceived and developed at the Lawrence Livermore National Laboratory (LLNL). Lumitron holds exclusive commercial development rights to these technologies.